West Pharmaceutical Services Inc
WST· NYSE
Released Apr 27, 2023, before the open
10-Q filed Apr 27, 2023, 27 days after period end · 0000105770-23-000023
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $716.60M | $720.00M | $670.70M | $491.50M |
| Net Income | $140.00M | $173.80M | $151.20M | $74.30M |
| EPS Diluted |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $1.85 |
| $2.29 |
| $1.99 |
| $0.99 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.